FY2025 · ended Dec 31, 2025 · Revenue $2.69M, +26.3% YoY · Filed Mar 30, 2026
QHSLab, Inc. (USAQ) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.7 million and net income of $457,417. As of Jun 30, 2026 it held $317,392 in cash and investments and $90,704 in total debt.
Revenue (TTM)
$3.02M
+24.6% vs year-ago TTM
Net income (TTM)
$-390,726
-5.5% vs year-ago TTM
Operating cash flow (TTM)
$-463,663
-710.4% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.02
+45.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
15.03M
+33.3% vs prior year
Net cash
$226,688
as of Jun 30, 2026
Operating margin
2.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- USAQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Palm Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 856984
- Former names
- USA EQUITIES CORP. (until Apr 19, 2022); AMERICAN BIOGENETIC SCIENCES INC (until Nov 16, 2015)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.7M | $2.1M | $1.4M | $1.2M | $1.4M |
| Operating income | $131,244 | $205,738 | -$240,158 | -$560,539 | -$502,258 |
| Net income | $457,417 | -$259,239 | -$468,362 | -$996,001 | -$770,176 |
| Diluted EPS | $0.02 | -$0.03 | -$0.05 | — | — |
| Operating cash flow | $178,118 | $142,437 | -$159,627 | -$350,994 | -$354,738 |
| Total assets | $2.2M | $1.8M | $1.7M | $2.0M | $2.2M |
| Total liabilities | $546,078 | $2.4M | $2.1M | $1.9M | $1.4M |
| Stockholders' equity | $1.6M | -$607,756 | -$375,617 | $76,245 | $824,066 |
| Cash and investments | $636,157 | $157,168 | $51,582 | $178,694 | $286,855 |
| Total debt | $90,704 | — | $546,052 | $342,391 | $253,865 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 26, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 21, 2026 | Apr 21, 2026 |
All 360 QHSLab, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.